Donald R. Branch

5.4k total citations
182 papers, 3.8k citations indexed

About

Donald R. Branch is a scholar working on Hematology, Immunology and Physiology. According to data from OpenAlex, Donald R. Branch has authored 182 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Hematology, 62 papers in Immunology and 47 papers in Physiology. Recurrent topics in Donald R. Branch's work include Blood groups and transfusion (64 papers), Erythrocyte Function and Pathophysiology (44 papers) and Platelet Disorders and Treatments (35 papers). Donald R. Branch is often cited by papers focused on Blood groups and transfusion (64 papers), Erythrocyte Function and Pathophysiology (44 papers) and Platelet Disorders and Treatments (35 papers). Donald R. Branch collaborates with scholars based in Canada, United States and Switzerland. Donald R. Branch's co-authors include Lawrence D. Petz, Danila Leontyev, Gordon B. Mills, Darinka Sakac, Yulia Katsman, Clifford A. Lingwood, Beth Binnington, Xue‐Zhong Ma, Anton Neschadim and Katherine A. Siminovitch and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Donald R. Branch

178 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald R. Branch Canada 35 1.4k 1.3k 1.2k 680 442 182 3.8k
Tsutomu Tsuji Japan 37 663 0.5× 2.4k 1.8× 1.0k 0.9× 536 0.8× 463 1.0× 168 4.9k
Tanya N. Mayadas United States 31 814 0.6× 1.5k 1.1× 2.2k 1.8× 359 0.5× 294 0.7× 45 4.8k
Philip E. Hass United States 24 1.7k 1.3× 1.8k 1.4× 2.1k 1.8× 273 0.4× 586 1.3× 36 5.6k
Noriko Okada Japan 29 788 0.6× 879 0.7× 1.6k 1.3× 307 0.5× 237 0.5× 136 3.2k
Ivan Cruz Moura France 35 619 0.4× 1.4k 1.0× 2.2k 1.9× 392 0.6× 360 0.8× 60 4.8k
Kenzaburo Tani Japan 38 1.2k 0.9× 2.4k 1.8× 1.4k 1.2× 467 0.7× 164 0.4× 225 5.4k
R. Duncan Campbell United Kingdom 40 858 0.6× 2.7k 2.0× 2.9k 2.4× 439 0.6× 468 1.1× 84 6.0k
Martin de Boer Netherlands 36 417 0.3× 1.4k 1.0× 2.7k 2.2× 571 0.8× 363 0.8× 106 4.2k
George Kannourakis Australia 27 743 0.5× 1.2k 0.9× 1.6k 1.4× 579 0.9× 126 0.3× 109 4.3k
Richard H. Weisbart United States 27 410 0.3× 1.2k 0.9× 1.6k 1.3× 426 0.6× 562 1.3× 81 3.5k

Countries citing papers authored by Donald R. Branch

Since Specialization
Citations

This map shows the geographic impact of Donald R. Branch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Branch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Branch more than expected).

Fields of papers citing papers by Donald R. Branch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Branch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Branch. The network helps show where Donald R. Branch may publish in the future.

Co-authorship network of co-authors of Donald R. Branch

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Branch. A scholar is included among the top collaborators of Donald R. Branch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Branch. Donald R. Branch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ye, Xianlin, Tong Li, Jinfeng Zeng, et al.. (2023). The high prevalence of occult hepatitis B infections among the partners of chronically infected HBV blood donors emphasizes the potential residual risk to blood safety. Journal of Medical Virology. 95(8). e29006–e29006. 7 indexed citations
3.
Boligan, Kayluz Frias, et al.. (2023). Small Molecule Drugs That Inhibit Phagocytosis. Molecules. 28(2). 757–757. 4 indexed citations
4.
Almizraq, Ruqayyah J., Kayluz Frias Boligan, Bonnie J.B. Lewis, et al.. (2023). Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid Arthritis. Pharmacology. 108(2). 176–187. 3 indexed citations
6.
Branch, Donald R., Regina M. Leger, Darinka Sakac, et al.. (2022). The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia. Blood Advances. 7(10). 2166–2170. 5 indexed citations
7.
Gil, Lázaro, et al.. (2022). THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets. PLoS ONE. 17(12). e0278365–e0278365. 9 indexed citations
8.
Xu, Miao, June Li, Miguel A. D. Neves, et al.. (2018). GPIbα is required for platelet-mediated hepatic thrombopoietin generation. Blood. 132(6). 622–634. 50 indexed citations
9.
Schneider, Christoph, Christian W. Keller, Isaak Quast, et al.. (2017). IVIG regulates the survival of human but not mouse neutrophils. Scientific Reports. 7(1). 1296–1296. 28 indexed citations
10.
Pendergrast, Jacob, Beth Binnington, Jeannie Callum, et al.. (2017). Incidence and Risk Factors for IVIG-Mediated Hemolysis. Blood. 130. 2398–2398. 4 indexed citations
11.
Sage, Valerie Le, Alessandro Cinti, Raquel Amorim, et al.. (2016). Ebola virus VP35 blocks stress granule assembly. Virology. 502. 73–83. 49 indexed citations
12.
Neschadim, Anton, Laura B. Pritzker, K. P. H. Pritzker, et al.. (2014). Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts. Endocrine Related Cancer. 21(3). 459–471. 15 indexed citations
13.
Yver, Matthieu, et al.. (2013). Isolated bone marrow Hodgkin lymphoma in a human immunodeficiency virus-negative patient: a second case. Leukemia & lymphoma. 55(7). 1675–1677. 3 indexed citations
14.
Li, Ye & Donald R. Branch. (2013). Process optimization and content determination of crude polysaccharide content from Ganoderma Lucidum Green Tea. Strait Pharmaceutical Journal. 1 indexed citations
16.
Olsson, Martin L., Darinka Sakac, Vered Yahalom, et al.. (2009). The human Pk histo-blood group antigen provides protection against HIV-1 infection. Blood. 113(20). 4980–4991. 50 indexed citations
17.
Lin, Yulia, Katerina Pavenski, Elianna Saidenberg, & Donald R. Branch. (2009). Blood Group Antigens and Normal Red Blood Cell Physiology: A Canadian Blood Services Research and Development Symposium. Transfusion Medicine Reviews. 23(4). 292–309. 12 indexed citations
18.
Sakac, Darinka, et al.. (2008). Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. Glycobiology. 19(1). 76–82. 23 indexed citations
19.
Shehata, Nadine, Yulia Lin, Jacob Pendergrast, & Donald R. Branch. (2007). Cellular Therapies: A Canadian Blood Services Research and Development Symposium. Transfusion Medicine Reviews. 21(4). 317–336. 6 indexed citations
20.
Fouillard, L, et al.. (1998). Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. Hematology. 3(5). 347–354. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026